Excessive telomere shortening has been demonstrated in inherited and acquired blood disorders, including aplastic anemia and myelodysplastic syndromes. It is possible that replicative exhaustion, owing to critical telomere shortening in hematopoietic progenitor cells (HPCs), contributes to the development of cytopenias in these disorders. However to date, a direct link between the telomere length (TL) of human HPCs and their proliferative potential has not been demonstrated. In the present investigation, the TL and level of telomerase enzyme activity (TA) detected in cord blood (CB)-derived HPCs was found to predict erythroid expansion (Po0.01 and P ¼ 0.01 respectively). These results were corroborated by a correlation between proliferation of erythroid cells and telomere loss (P ¼ 0.01). In contrast, no correlations were found between initial TL, telomere loss or TA and the expansion of other myeloid lineagecommitted cells. There was also no correlation between TL or TA and the number of clonogenic progenitors, including primitive progenitors derived from long-term culture. Our investigations revealed upregulation of telomerase to tumor cell levels in CD34À cells undergoing erythroid differentiation. Together, these results provide new insight into the regulation of TL and TA during myeloid cell expansion and demonstrate that TL is an important determinant of CB-derived erythroid cell proliferation. Leukemia (2007) 21, 983-991.
Introduction
Telomere dysfunction is implicated in the pathogenesis of a number of inherited and acquired blood disorders, including preleukemic conditions and acute leukemias. [1] [2] [3] [4] [5] [6] Telomeres are composed of TTAGGG DNA repeats and play a critical role in the maintenance of genomic integrity (reviewed in de Lange 7 ). However, in normal somatic cells, telomeres shorten with each cell division until they eventually reach a critically short length and become dysfunctional. Telomere shortening in specific types of human cells, such as fibroblasts and endothelial cells, has been associated with the induction of an irreversible growth arrest, referred to as senescence. [8] [9] [10] Murine models suggest that telomere shortening may also contribute to the replicative exhaustion of hematopoietic stem cells (HSCs), which is evident upon serial bone marrow transplantation. [11] [12] [13] Observations of declining HSC proliferative potential during development and aging in humans are also consistent with hematopoietic senescence. 14, 15 Telomere shortening in the human hematopoietic system has been demonstrated in hematopoietic progenitors (HPCs) and their progeny during in vitro expansion and in blood leukocytes during aging in vivo. [16] [17] [18] [19] [20] [21] Telomere shortening is accelerated in recipients of HSC transplants, presumably owing to increased hematopoiesis. [22] [23] [24] Excessive telomere shortening has also been demonstrated in patients with myelodysplastic syndromes (MDS), Fanconi's anemia and aplastic anemia, which suggests that increased HSC turnover and senescence may underlie these disorders. [2] [3] [4] Furthermore, critical telomere shortening may also contribute to the generation of chromosomal abnormalities and upregulation of the enzyme telomerase, which drives progression of preleukemic conditions to acute leukemias. 25 Upregulation of telomerase promotes continued proliferation of leukemic cells by catalyzing addition of TTAGGG repeats at chromosome-ends, thereby circumventing senescence. [26] [27] [28] Pioneering investigations demonstrated that the telomere length (TL) of human fibroblasts is a more accurate predictor of proliferative capacity than the age of the donor or the time in culture. 9, 29 More recent investigations confirmed that TL is a critical determinant of replicative lifespan by demonstrating that overexpression of the catalytic component of telomerase (hTERT) extends telomeres and increases the proliferative capacity of human fibroblasts and epithelial cells. 30, 31 However, senescence may also be induced by telomere-independent mechanisms and direct evidence of a relationship between TL and the replicative potential of human hematopoietic cells has been elusive. [32] [33] [34] [35] At least three independent groups of investigators found that hTERT-transduction of human HPCs does not significantly affect TL or proliferation. [36] [37] [38] Thus far, the most direct link between TL and the replicative capacity of human HPCs is provided by studies that compared TL and proliferation of CD34 þ HPCs derived from fetal liver, umbilical cord blood (CB) and adult bone marrow-derived cells. 14, 17 However, those studies could not discriminate between the impact of age (or developmental stage) versus TL on the proliferative potential of HPCs. At birth, TL of HPCs varies broadly and twin studies suggest TL may be genetically set. 5, 39, 40 Evidence of a direct relationship between TL and hematopoietic cell proliferation may have important implications for predicting susceptibility to hematologic disorders and the suitability for HPC donations for transplantation.
The present investigations compare the TL and proliferative potential of cord blood-derived CD34 þ cells. The results demonstrate that TL predicts expansion of CB HPCs along erythroid, but not granulocytic, monocytic or megakaryocytic lineages. Furthermore, the level of telomerase activity in CB CD34 þ cells correlated exclusively with erythroid proliferative potential.
Materials and methods

Isolation of CD34
þ cells from CB /ml for 1 week in 20% fetal calf serum (FCS, Trace Scientific, Melbourne, Australia), 100 ng/ml stem cell factor (SCF, Amgen, Thousand Oaks, CA, USA), 100 ng/ml thrombopoietin (TPO, Peprotech, Rocky Hill, NJ, USA) and 100 ng/ml FLT-3 ligand (FLT-3L, Amgen) (STF), plus 50 mg/ml gentamycin and 200 mM glutamine in Isocove's modified Dulbecco's media (IMDM, Invitrogen, Carlsbad, CA, USA), before being cultured at 4 Â 10 4 /ml in the cytokine combinations described in Table 1 . Base media for monocytic and granulocytic cultures was 20% IMDM, whereas megakaryocyte and erythroid cultures were grown in serum-free QBSF60 (Quality Biologicals, Gaithersburg, MD, USA). All cultures were grown at 37 1C in 5% CO 2 . Each week, cells were harvested for assessment of expansion and differentiation. Differentiation was assessed by flow cytometry after staining cells with PE-conjugated CD14 (Becton Dickinson), PE-conjugated CD114 (Becton Dickinson), PE-conjugated CD61 (Becton Dickinson) and fluorescein isothiocyanate (FITC)-conjugated Glycophorin A (GlyA) (Dako Cytomation, Glostrup, Denmark) ( 
Progenitor assays and LTC
Clonogenic progenitors were quantified in semi-solid media containing 1% methylcellulose (Fluka, Seelze, Germany), 30% FCS, 0.1 M b-Mercaptoethanol (Sigma, St Louis, MO, USA), 200 mM glutamine (Invitrogen), 0.1 mM hemin (Sigma), 20 ng/ml SCF, 50 ng/ml interleukin-3 (IL-3, Novartis, Basel, Switzerland), 20 ng/ml IL-6, (Novartis), 6 U/ml erythropoietin (EPO, Amgen) and 100 ng/ml granulocyte-colony-stimulating factor (G-CSF, Amgen). After 14 days of culture at 371C in 5% CO 2 , granulocyte macrophage colony-forming units (CFU-GM), granulocyte, erythrocyte, megakaryocyte, macrophage-CFU (CFU-GEMM) and erythroid burst-forming units (BFU-E), consisting of more than 50 cells per colony, were scored using an inverted microscope. Average values from triplicate plates were used in statistical calculations. For the assessment of primitive progenitors, CD34
þ cells (4 Â 10 4 /ml) were expanded for 1 week in STF, then 5 Â 10 4 cells were co-cultured with a confluent monolayer of MS-5 murine stromal cells in triplicate T25 flasks that were demi-depopulated once per week, as described previously. 41 After 5 weeks of LTC, half of the nonadherent cells were co-cultured for a further 5 weeks on a second MS-5 monolayer. At weeks 5 and 10, cells from triplicate flasks were pooled and primitive progenitors were quantified in clonogenic assays. The total number of colony-forming cells (CFC) was corrected for expansion between weeks 0 and 1, so that values represent CFC per 10 000 initial (day 0) input cells.
TRF assay
Mean TL was measured using the TeloTAGGG Telomere Length Assay kit (Roche, Mannheim, Germany) as described. 42 Genomic DNA, digested with HinfI and RsaI, was fractionated through a 0.7% agarose gel in 0.5 Â TBE buffer (90 mM Tris, 90 mM boric acid and 4 mM ethylenediaminetetraacetic acid) for 26 h at 65 V. Following Southern blot transfer to nylon membranes, the membranes were hybridized with a 1:5000 dilution of the telomere probe. The reproducibility of telomeric restriction fragment assay (TRF) analyses was assessed by repeated quantification of the mean TL of the control DNA Table 1 Lineage-specific expansion of CB cells Abbreviations: CB, umbilical cord blood; EPO, erythropoietin; G-CSF, granulocyte-colony stimulating factor; PD, population doublings. CD34+ cells were expanded in 100 ng/ml SCF, 100 ng/ml FLT-3L, 100 ng/ml TPO for 7 days, then cultured in the cytokine combinations shown until replicative exhaustion.
(Roche). The results generated a standard deviation of 200 bp (mean ¼ 7.86 kbp, range from 7.50-8.04 kbp, n ¼ 6).
Quantification of TA
Telomerase enzyme activity (TA) was quantified using the realtime polymerase chain reaction-based Quantitative Telomerase Detection (QTD) kit according to the manufacturer's instructions (Allied Biotech, Ijamsville, MD, USA). Briefly, whole cellular protein was extracted in lysis buffer and 25 ng of protein was assayed in each reaction. Whole-cell extract from the SK-N-SH neuroblastoma cell line (25, 10, 5, 1, 0.5 and 0.1 ng) was used to construct a standard curve for each assay. The cycle at which each product reached a threshold where all samples were in a logarithmic phase (Ct) was used to calculate TA of each sample using the formula generated by the standard curve, then normalizing the average of duplicate values to 10 ng SK-N-SH. Lysis buffer and 10 ng of heat-inactivated SK-N-SH (851C for 10 min) were used as negative controls. Each sample was tested in two to three independent experiments.
Statistics
All statistical analyses were performed using GraphPad Prism 4.0. Results were considered significant when Po0.05.
Results
Expansion without net telomere loss during culture in STF, but not STF plus IL-6
The central aim of this study was to investigate the relationship between TL and the proliferative potential of CB-derived CD34 þ cells expanded under culture conditions that would enable assessment of different myeloid cell progeny. However in general, the yield of CD34 þ cells obtained was insufficient for all of the required assays. Hence, preliminary experiments were performed to test whether the TL of expanded CB cells could be used as a surrogate for freshly isolated CD34 þ cells. For these preliminary investigations, eight larger CB samples of at least 2.5 Â 10 6 CD34 þ cells were expanded in two cytokine combinations; STF or STF plus IL-6 (STF6). Both of these cytokine combinations were previously shown to expand CBderived HPCs without apparent loss of long-term proliferative potential. 43, 44 Furthermore, STF6 was shown to promote longterm expansion of primitive HPCs with minimal telomere loss. 43 In our hands, there was no significant difference in total cell expansion in STF (mean ¼ 5.0270.21 PDs) versus STF6 (mean ¼ 5.3470.50 PDs). Before expansion (week 0), the mean TL of the eight CD34 þ CB samples ranged from 9.4 to 11.1 kbp (median ¼ 10.2 kbp). Following 7-day expansion, the mean TL of cells in STF cultures was not significantly different to unexpanded CD34 þ cells (median TL ¼ 10.2 kbp, P ¼ 0.84 Wilcoxon-signed-rank test) (Figure 1a and b) . In contrast, TL decreased significantly during expansion in STF6 (median TL ¼ 9.3 kbp, Po0.01 Wilcoxon-signed-rank test) (Figure 1a and b). Thus, there was a substantial impact on telomere attrition by the addition of IL-6. The difference in telomere loss did not appear to be explained by proliferation, as expansion in STF and STF6 was similar. Telomere loss in STF6 most likely reflected TL changes in differentiating (CD34À) cells, as a previous study demonstrated long-term maintenance of TL in CD34 þ cells that were FACS sorted from STF6 expansion cultures. 43 Irrespective of those data, the results shown here demonstrate that the mean TL of CB cells expanded for 7 days in STF can be used as a surrogate for the TL of unexpanded CD34 þ cells.
To obtain baseline measurements of TL for further analyses, 43 CB-derived CD34 þ samples were expanded for 7 days in STF. On average, total cell number increased by 35.7711.8-fold (5.2 þ 3.5 PDs) during expansion. There was an average of 9.0-fold expansion of CD34 þ cells and 18.6-fold expansion of CFC. After 7 days of expansion, mean TL of 40 of these samples ranged from 8.2 to 12.6 kbp, with a mean of 10.171.1 kbp (Figure 1c ) (TL could not be accurately measured in three samples that did not resolve well-enough in the TRF gel for quantitative analysis). These results are consistent with the previously reported range and mean TRF measurements of uncultured CB CD34 þ cells. 5, 17 TA was measured in representative samples by quantitative real-time PCR. Linear regression analysis showed no correlation between TA measured in CB cells before expansion and the mean TL of STF-expanded cells (P ¼ 0.74, n ¼ 22). There were also no correlations between either TL or TA and total cell 
Expansion of lineage-committed myeloid cells
To assess the proliferative potential of specific myeloid progeny, the first 31 CB samples that were expanded in STF for 7 days were split into four different cytokine combinations, SFM, SFG, ST6 and SE, which promote expansion and differentiation of monocytic, granulocytic, megakaryocytic and erythroid cells, respectively ( Table 1 ). The cells were replated at low-density each week until replicative exhaustion was evident. Weekly FACS analysis demonstrated that the proportion of CD34 þ cells rapidly declined in each culture condition, whereas the expected lineage-committed cell type reached at least 50% of the cultures within 2 weeks (Figure 2 ). The decrease in the purity of the erythroid and megakaryocytic cultures that was evident after weeks 2-3 was likely due to the propensity for these cell types to undergo apoptosis upon differentiation, whereas differentiated monocytes and granulocytes were more persistent in SFM and SFG cultures. Morphologic examination of cytocentrifuged preparations of cells from ST6 and SE cultures at weeks 2-3 confirmed that the cultures were dominated by megakaryocytes and erythroid cells (respectively), with some immature cells, but very few monocytic or granulocytic cells evident at these time points (Supplementary Figure 1 and additional data not shown).
Results from weekly FACS analyses and total viable cell counts were used to calculate the maximum number of PDs attained by lineage-committed cells. Extensive variations in the proliferative potential of different cell types and among individual CB samples were noted. There was an overall trend for monocytic cells to attain the greatest, and megakaryocytes the least PDs (Table 1) . However, these trends varied among individual samples (data not shown), which provided sound rationale for investigating TL or TA in specific myeloid cell types, rather than mixed cultures.
Modulation of TA during myeloid cell expansion
TA was assessed from weeks 0-3 in representative samples (n ¼ 12) by quantitative real-time PCR. Consistent with previously published reports, TA was relatively low in unstimulated CD34 þ cells. 17, 45, 46 During expansion in STF, telomerase was upregulated by up to 24-fold (from 0.07 to 1.69) and on average by threefold (from 0.15 to 0.50) (Figure 2, right axis) . Telomerase was rapidly extinguished to levels below unstimulated cells during the following week (weeks 1-2) when cells were transferred to SFM or SFG, and was more slowly downregulated during weeks 1-3 in cells cultured in ST6. In contrast, cells cultured in SE exhibited a further increase in TA during the first week in differentiating conditions (weeks 1-2). TA in these cultures reached levels that were up to 75-fold (from 0.02 to 1.15), and on average sixfold higher (from 0.15 to 0.89) than unstimulated cells. Notably, there were no detectable CD34 þ cells in the SE cultures when TA peaked at week 2. On average, GlyA þ cells accounted for approximately 50% of the cell content of SE cultures at this time point. However, morphologic examination of cytocentrifuged slides revealed a higher erythroid content than estimated by FACS analysis. For instance, cultures that were 31-77% GlyA þ by FACS analysis were scored as 70-91% erythroid by morphologic examination (data not shown). As the GlyA antigen is expressed relatively late during erythroid differentiation, the discrepancy between FACS and morphologic analyses is likely to be accounted for by GlyAerythroblasts in the cultures. Together, these results suggest that CD34-lineage-committed erythroid precursors express relatively high levels of TA. 
TL and TA predict erythroid proliferation
Regression analysis was performed to determine whether the mean TL of the starting population of cells was indicative of the proliferative potential of specific myeloid cell types. These analyses revealed a highly significant correlation between the maximum number of PDs attained by GlyA þ cells in SE cultures and the mean TL of 28 CB samples measured at week 1 (Po0.01). In contrast, there was no correlation between TL and the expansion of monocytes, granulocytes or megakaryocytes (P ¼ 0.93, 0.89 and 0.81, respectively) (Figure 3a) .
TL was also measured at week 3 in samples that had sufficient cells at this time point. Telomere loss and the rate of telomere attrition was calculated between weeks 1 and 3 when lineagecommitted cells were predominant (Figure 3b ). Despite considerable variations among individuals, there was no significant difference in the rate or amount of telomere shortening among the four culture conditions (Kruskal-Wallis test, P ¼ 0.22 and P ¼ 0.31, respectively). Thus, the differing relationships between TL and proliferation of erythroid cells versus other cell types did not appear to be due to telomere dynamics induced by culture conditions. In regression analyses, there was no relationship between the rate of telomere shortening and expansion of any cell type (data not shown). There was also no relationship observed between the absolute amount of telomere loss and proliferation in SFM, SFG or ST6 cultures (P ¼ 0.37, 0.85 and 0.84, respectively) (Figure 3c) . However, the extent of telomere shortening in SE cultures between weeks 1 and 3 (median value ¼ 1.4 Kbp) showed a significant correlation with proliferation of GlyA þ cells during this period (P ¼ 0.01). These results demonstrate that telomere shortening in SE cultures was principally due to cell replication and corroborate the significance of TL as a determinant of the erythroid potential of CBderived CD34 þ cells. It was notable that induction of high levels of telomerase did not prevent dramatic telomere shortening in SE cultures.
In concert with the observed relationships between telomere dynamics and erythroid proliferation, linear regression analysis also revealed a significant correlation between the level of TA in unstimulated CB CD34 þ cells and expansion of erythroid (P ¼ 0.01), but not monocytic, granulocytic or megakaryocytic cells (P ¼ 0.58, 0.65 and 0.47, respectively) (Figure 3d ). Although the sample numbers were limited in the telomerase assay, the reiteration of a relationship with erythroid proliferation was striking. Overall, these data show that HPC-driven erythroid proliferation is intricately linked to TL and TA in the initial cell population, as well as telomere loss during expansion and differentiation. Telomere
Relationship between TL, TA and clonogenic progenitors
To further explore the relationship between TL and the proliferative potential of CB CD34 þ cells, primary (week 0) and secondary (after 7-day expansion in STF) CFC, as well as primitive progenitors from weeks 5 and 10 LTCs, were quantified in clonogenic assays (Figure 4a and b) . Despite a considerable range in primary and secondary CFC content, regression analysis revealed no significant correlation between the initial TL or TA and CFU-GEMM, BFU-E, CFU-GM or total CFC quantified at week 0 or week 1 (data not shown). Expansion in STF favored CFU-GM (31.3-fold) over CFU-GEMM (no expansion) and BFU-E (8.6-fold), which would have contributed to the greater production of monocytic and granulocytic cells compared with megakaryocytic and erythroid cells in the differentiation conditions (Table 1) . Primitive progenitors were quantified as CFC enumerated after 7-day STF expansion, then 5 and 10 weeks of LTC. There was a broad range in week 5 and 10 CFC content (Figure 4b ). However, there was no correlation between TL and week 5 or 10 primitive progenitors in the 39 samples that could be assayed for TL. There was also no correlation between TA and either week 5 or 10 CFC in 22 representative samples (Figure 4c and d) .
Discussion
These investigations demonstrate a correlation between the mean TL of CB-derived CD34 þ cells and the proliferative potential of their erythroid progeny. Further, we have shown that telomere loss during erythroid proliferation is proportionate to the replication of the cells. These results provide the first direct evidence that TL is a determinant of erythroid cell proliferation and provide further support for the possibility that short telomeres contribute to erythropoietic impairment in patients with MDS and aplastic anemia. However, dysplasia in MDS and aplastic anemia is usually multilineage, involving granulocytes and megakaryocytes, as well as erythroid cells. 47 Strikingly, no relationship between TL and production of granulocytes, megakaryocytes or monocytes was observed in this study. The specificity of the correlation between TL and expansion of erythroid cells suggests that telomere-independent factors, such as oxidative stress or over activity of mitogenic signaling pathways (RAS-MAPK), which induce premature senescence, may limit in vitro proliferation of monocytic, granulocytic and megakaryocytic cells under these culture conditions. 32, 33, 48 Further investigation of telomere dynamics and the replicative lifespan of myeloid subsets in vivo, where mitogenic stimulation is appropriately regulated and the cells are subject to less oxidative stress, will address this issue. However, irrespective of in vivo studies, delineation of the mechanisms that limit ex vivo expansion of myeloid cells, particularly megakaryocytes and granulocytes, will remain an important goal.
In the present study, there was no net telomere shortening in CB CD34
þ cells that were expanded for 1 week in STF, which provided impetus for using the TL of these cells as a surrogate baseline. Pending the development of an accurate method for measuring the TL of smaller numbers of cells, it will be worth repeating our studies without the STF expansion step, as our data and independent investigations show that STF favors expansion of CFU-GM and outgrowth of granulocytic and monocytic cells. 49 It was notable that we found no relationship between TL and granulocytes or monocytes under these favorable conditions. However, it will be important to further explore the significance of TL in megakaryocyte expansion under alternative culture conditions. CD34 þ subpopulations derived from adult versus neonatal sources display a differential response to cytokine stimulation. 50 Hence in addition to the present study of CB cells, it will be of value to assess the relationship between TL and proliferation of myeloid subsets derived from normal adult bone marrow. The telomere dynamics and the replicative potential of adult bone marrow cells in vitro may be directly relevant to adult MDS, which is thought to be due (at least in part) to telomere attrition during aging. However, telomere attrition may also contribute to certain subsets of childhood MDS (refractory anemia and refractory anemia with excess blasts), which exhibit clinicopathologic features of adult MDS, including multilineage dysplasia, chromosome abnormalities and a propensity for leukemic evolution. 51 Indeed, abnormally short telomeres have been reported in Fanconi's anemia patients, who typically develop MDS symptoms around 5 years of age. 2 The present report shows that at birth, TL in CD34 þ HPCs may vary by 4.5 kbp. These results raise the possibility that individuals born with shorter HPC TLs may be more susceptible to critical telomere shortening and erythroid dysfunction during aging. However, other parameters, such as the rate of cell proliferation in vivo and the amount of telomere shortening per PD, would also contribute to the time taken to reach a critical TL in vivo. Significantly, our data demonstrated considerable variation in the rate of telomere loss among individuals, and this value alone was not predictive of the proliferative potential of any myeloid cell type.
Our results showing induction of TA during 7-day expansion in STF are consistent with previous studies that showed rapid (3-8 days) induction of telomerase when CD34 þ cells were cultured in broadly acting cytokine cocktails. 17, 45 In the latter studies, cytokine-induced upregulation of telomerase appeared to be principally due to the activation of the CD34 þ population, as the CD34À fraction of expanded cultures had very low-levels of TA. Hence, it is generally thought that telomerase is downregulated during differentiation and that telomerasepositive cells are confined to the CD34 þ fraction of the myeloid compartment. Our results showing that TA was downregulated to negligible levels in SFM, SFG and ST6 cultures during weeks 1-2, as CD34 þ cells were replaced with monocytic, granulocytic and megakaryocytic cells support this concept. Conversely, TA was upregulated in SE cultures during weeks 1-2 and peaked at week 2, when there were no detectable CD34 þ cells. These data provide the first evidence for TA in differentiated myeloid cells. Furthermore, as erythroid cells were predominant when TA peaked in SE cultures, these results suggest that telomerase may be transiently upregulated during erythroid differentiation and show that telomerase is differentially regulated in response to different cytokines and/or different myeloid cell differentiation programs. We cannot exclude the possibility that TA was upregulated in a CD34Ànegative progenitor or a less abundant, non-erythroid cell type. However, our data provide no evidence for induction of telomerase during monocytic, granulocytic and megakaryocytic differentiation.
Despite induction of TA in SE cultures to levels that were comparable to the SK-N-SH neuroblastoma cell line, there was rapid telomere shortening in these cultures between weeks 1 and 3. These findings corroborate evidence of a dissociation between TA and telomere maintenance in hematopoietic cells. 37 The subcellular localization of telomerase enzyme components and/or impaired telomere accessibility mediated by telomere-binding proteins may explain the apparent dissociation of TA measured in vitro and telomere maintenance in vivo. 52 However, it is notable that a recent investigation demonstrated long-term maintenance of TL in CD34 þ cells cultured under specific self-renewal conditions. 43 TL is also maintained in telomerase-positive immortal leukemia cell lines. Clearly, further investigation into the positive and negative regulators of TL in hematopoietic cells is warranted.
Overall, these investigations demonstrate that quantitative measurement of TA and/or the mean TL of CB-derived CD34 þ cells provides an indication of erythroid proliferative potential in vitro. However, TL was not predictive of progenitor content, nor monocytic, granulocytic or megakaryocytic cell production. This study provides the first evidence of high levels of TA in CD34À myeloid cells and adds to a body of evidence that describes a dissociation between TA and telomere maintenance in hematopoietic cells.
